DUGGAN ROBERT W bought SMMT
September 10, 2025 · Form 4 insider transaction
DUGGAN ROBERT W bought 333,394 shares of Summit Therapeutics Inc. at $17.68 per share, a transaction worth $5.89M. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
333,394
Price
$17.68
Total value
$5.89M
InsiderDUGGAN ROBERT W
Role—
SecurityCommon Stock
Transaction codeP: Open-market purchase
Transaction dateSeptember 10, 2025
Filing dateSeptember 11, 2025
Shares owned after556,088,090
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The reported price in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $17.49 to $17.89 per share, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.